Predictive Oncology Inc (POAI)
1.435
-0.32
(-18.47%)
USD |
NASDAQ |
May 31, 16:00
1.43
0.00 (0.00%)
After-Hours: 20:00
Predictive Oncology Enterprise Value: 0.7277M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 0.7277M |
| May 30, 2024 | 2.061M |
| May 29, 2024 | 2.758M |
| May 28, 2024 | 3.394M |
| May 24, 2024 | 1.279M |
| May 23, 2024 | 1.482M |
| May 22, 2024 | 1.528M |
| May 21, 2024 | 1.568M |
| May 20, 2024 | 1.774M |
| May 17, 2024 | 1.733M |
| May 16, 2024 | 1.733M |
| May 15, 2024 | 1.979M |
| May 14, 2024 | 1.979M |
| May 13, 2024 | 1.692M |
| May 10, 2024 | 1.528M |
| May 09, 2024 | 2.061M |
| May 08, 2024 | 1.979M |
| May 07, 2024 | 1.528M |
| May 06, 2024 | 2.061M |
| May 03, 2024 | 2.266M |
| May 02, 2024 | 1.815M |
| May 01, 2024 | 1.610M |
| April 30, 2024 | 0.6254M |
| April 29, 2024 | 0.2863M |
| April 26, 2024 | 0.9766M |
| Date | Value |
|---|---|
| April 25, 2024 | 1.586M |
| April 24, 2024 | 0.2859M |
| April 23, 2024 | 0.0827M |
| April 22, 2024 | -0.3642M |
| April 19, 2024 | -0.4048M |
| April 18, 2024 | -0.4857M |
| April 17, 2024 | 0.1181M |
| April 16, 2024 | 0.489M |
| April 15, 2024 | 0.9766M |
| April 12, 2024 | 1.992M |
| April 11, 2024 | 2.074M |
| April 10, 2024 | 1.870M |
| April 09, 2024 | 1.992M |
| April 08, 2024 | 2.602M |
| April 05, 2024 | 2.625M |
| April 04, 2024 | 2.805M |
| April 03, 2024 | 2.805M |
| April 02, 2024 | 3.170M |
| April 01, 2024 | 4.064M |
| March 31, 2024 | 5.202M |
| March 28, 2024 | 1.783M |
| March 27, 2024 | 2.717M |
| March 26, 2024 | 2.270M |
| March 25, 2024 | 2.027M |
| March 22, 2024 | 2.270M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-8.288M
Minimum
Apr 26 2023
89.14M
Maximum
Mar 11 2021
16.55M
Average
15.59M
Median
Enterprise Value Benchmarks
| icad Inc | 18.20M |
| Perspective Therapeutics Inc | 680.29M |
| Semler Scientific Inc | 144.56M |
| Xtant Medical Holdings Inc | 116.30M |
| Asensus Surgical Inc | 52.33M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.219M |
| Revenue (Quarterly) | 0.4196M |
| Total Expenses (Quarterly) | 4.656M |
| EPS Diluted (Quarterly) | -1.04 |
| Gross Profit Margin (Quarterly) | 55.34% |
| Profit Margin (Quarterly) | -1.01K% |
| Earnings Yield | -254.4% |
| Normalized Earnings Yield | -251.73 |